首页> 美国卫生研究院文献>Non-coding RNA Research >A novel enhancer RNA Hmrhl positively regulates its host gene phkb in chronic myelogenous leukemia
【2h】

A novel enhancer RNA Hmrhl positively regulates its host gene phkb in chronic myelogenous leukemia

机译:新型增强子RNA Hmrhl在慢性粒细胞性白血病中正调控其宿主基因phkb

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Noncoding RNAs are increasingly being accredited with key roles in gene regulation during development and disease. Here we report the discovery and characterization of a novel long noncoding RNA, Hmrhl, which shares synteny and partial sequence similarity with the mouse lncRNA, Mrhl. The human homolog, Hmrhl, transcribed from intron 14 of gene, is 5.5 kb in size, expressed in all tissues examined and is associated with chromatin. Analysis of Hmrhl locus using ENCODE database revealed that it exhibits hallmarks of enhancers like the open chromatin configuration, binding of transcription factors, enhancer specific histone signature etc. in the K562 Chronic Myelogenous Leukemia (CML) cells. We compared the expression of Hmrhl in the normal lymphoblast cell line, GM12878, with that of K562 cells and lymphoma samples and show that it is highly upregulated in leukemia as well as several cases of lymphoma. Further, we validated the enhancer properties of Hmrhl locus in K562 cells with the help of ChIP-qPCR and Luciferase assay. Moreover, siRNA mediated down-regulation of Hmrhl in K562 cells leads to a concomitant down regulation of its parent gene, , showing that Hmrhl functions as an enhancer RNA and positively regulates its host gene, in chronic myelogenous leukemia. This study is significant in view of the fact that a better understanding of mechanism of gene regulation under normal conditions and its perturbation in cancer could in turn help in its therapeutic intervention through molecular medicine/RNA based drug discovery.
机译:在发育和疾病期间,非编码RNA在基因调控中的关键作用越来越得到认可。在这里,我们报告发现和表征新型长非编码RNA Hmrhl,它与小鼠lncRNA Mrrhl共享同义和部分序列相似性。从基因内含子14转录的人类同源物Hmrhl大小为5.5kb,在所有检查的组织中表达,并与染色质相关。使用ENCODE数据库对Hmrhl基因座进行的分析表明,它在K562慢性粒细胞白血病(CML)细胞中表现出增强子的特征,例如开放的染色质构型,转录因子的结合,增强子特异性组蛋白签名等。我们比较了正常淋巴母细胞细胞系GM12878中Hmrhl的表达与K562细胞和淋巴瘤样品中Hmrhl的表达,并发现它在白血病以及一些淋巴瘤病例中均上调。此外,我们借助ChIP-qPCR和荧​​光素酶测定法验证了Hmrhl基因在K562细胞中的增强子特性。此外,在慢性粒细胞白血病中,siRNA介导的KmRNA细胞中Hmrhl的下调导致其亲本基因的同时下调,这表明Hmrhl充当增强子RNA并正向调节其宿主基因。鉴于以下事实,这项研究具有重要意义:更好地了解正常条件下的基因调控机制及其在癌症中的扰动反过来可以通过基于分子医学/ RNA的药物发现帮助其进行治疗干预。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号